NEWMarkets
BioCardia (BKD) CEO Peter Altman Buys $5,550 in Company Stock
Published on 4/29/2026

AI Summary
Peter Altman, the CEO of BioCardia (BKD), purchased $5,550 worth of common stock in the company. This transaction highlights Altman's confidence in the company's future performance and aligns his interests with other shareholders. Insider buying can sometimes indicate a positive outlook on company performance, influencing investor sentiment. BioCardia is likely to see increased interest from investors following this news.



